ERS Special Article. The Postinjury Inflammatory State and the Bone Marrow Response to Anemia

Rationale: The pathophysiology of persistent injury‐associated anemia is incompletely understood, and human data are sparse. Objectives: To characterize persistent injury‐associated anemia among critically ill trauma patients with the hypothesis that severe trauma would be associated with neuroendocrine activation, erythropoietin dysfunction, iron dysregulation, and decreased erythropoiesis. Methods: A translational prospective observational cohort study comparing severely injured, blunt trauma patients who had operative fixation of a hip or femur fracture (n = 17) with elective hip repair patients (n = 22). Bone marrow and plasma obtained at the index operation were assessed for circulating catecholamines, systemic inflammation, erythropoietin, iron trafficking pathways, and erythroid progenitor growth. Bone marrow was also obtained from healthy donors from a commercial source (n = 8). Measurements and Main Results: During admission, trauma patients had a median of 625 ml operative blood loss and 5 units of red blood cell transfusions, and Hb decreased from 10.5 to 9.3 g/dl. Compared with hip repair, trauma patients had higher median plasma norepinephrine (21.9 vs. 8.9 ng/ml) and hepcidin (56.3 vs. 12.2 ng/ml) concentrations (both P < 0.05). Bone marrow erythropoietin and erythropoietin receptor expression were significantly increased among patients undergoing hip repair (23% and 14% increases, respectively; both P < 0.05), but not in trauma patients (3% and 5% increases, respectively), compared with healthy control subjects. Trauma patients had lower bone marrow transferrin receptor expression than did hip repair patients (57% decrease; P < 0.05). Erythroid progenitor growth was decreased in trauma patients (39.0 colonies per plate; P < 0.05) compared with those with hip repair (57.0 colonies per plate; P < 0.05 compared with healthy control subjects) and healthy control subjects (66.5 colonies per plate). Conclusions: Severe blunt trauma was associated with neuroendocrine activation, erythropoietin dysfunction, iron dysregulation, erythroid progenitor growth suppression, and persistent injury‐associated anemia. Clinical trial registered with www.clinicaltrials.gov (NCT 02577731).

[1]  T. Ganz,et al.  Immunoassay for human serum erythroferrone. , 2017, Blood.

[2]  C. Magnon,et al.  Cholinergic Signals from the CNS Regulate G-CSF-Mediated HSC Mobilization from Bone Marrow via a Glucocorticoid Signaling Relay. , 2017, Cell stem cell.

[3]  R. Gamelli,et al.  Terminal Maturation of Orthochromatic Erythroblasts Is Impaired in Burn Patients. , 2017, Journal of burn care & research : official publication of the American Burn Association.

[4]  P. Efron,et al.  Daily propranolol administration reduces persistent injury-associated anemia after severe trauma and chronic stress , 2017, The journal of trauma and acute care surgery.

[5]  P. Ferrada,et al.  Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis , 2017, World Journal of Emergency Surgery.

[6]  R. Gamelli,et al.  Myelo-erythroid commitment after burn injury is under β-adrenergic control via MafB regulation. , 2017, American journal of physiology. Cell physiology.

[7]  Michael A. Smith,et al.  Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia , 2016, The journal of trauma and acute care surgery.

[8]  E. Wood,et al.  Anemia and iron-restricted erythropoiesis in traumatic critical illness , 2016, The journal of trauma and acute care surgery.

[9]  R. Wilson,et al.  Impact of minimizing diagnostic blood loss in the critically ill. , 2015, Surgery.

[10]  A. Mohr,et al.  Chronic restraint stress after injury and shock is associated with persistent anemia despite prolonged elevation in erythropoietin levels , 2015, The journal of trauma and acute care surgery.

[11]  D. Linehan,et al.  CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. , 2015, Cancer research.

[12]  J. Lipton,et al.  G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept , 2015, Bone Marrow Transplantation.

[13]  D. Swinkels,et al.  Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. , 2014, Blood.

[14]  E. Moore,et al.  A Multicenter, Randomized Clinical Trial of IV Iron Supplementation for Anemia of Traumatic Critical Illness* , 2014, Critical care medicine.

[15]  D. Livingston,et al.  Early propranolol administration to severely injured patients can improve bone marrow dysfunction , 2014, The journal of trauma and acute care surgery.

[16]  S. Rivella,et al.  IDENTIFICATION OF ERYTHROFERRONE AS AN ERYTHROID REGULATOR OF IRON METABOLISM , 2014, Nature Genetics.

[17]  T. Ganz,et al.  Hepcidin Induction by Pathogens and Pathogen-Derived Molecules Is Strongly Dependent on Interleukin-6 , 2013, Infection and Immunity.

[18]  M. Tran,et al.  Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. , 2013, Transfusion medicine reviews.

[19]  D. Bowden,et al.  Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study. , 2013, Blood.

[20]  Stephen Mok,et al.  CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. , 2013, Cancer research.

[21]  P. Rameshwar,et al.  β-blockade protection of bone marrow following trauma: the role of G-CSF. , 2011, The Journal of surgical research.

[22]  D. Livingston,et al.  Impact of enhanced mobilization of bone marrow derived cells to site of injury. , 2011, The Journal of trauma.

[23]  P. Rameshwar,et al.  Dose-response relationship between norepinephrine and erythropoiesis: evidence for a critical threshold. , 2010, The Journal of surgical research.

[24]  P. Rameshwar,et al.  Hematopoietic progenitor cell mobilization is mediated through beta-2 and beta-3 receptors after injury. , 2010, The Journal of trauma.

[25]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[26]  A. Randolph,et al.  Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. , 2008, American journal of respiratory and critical care medicine.

[27]  T. Fabian,et al.  Efficacy and safety of epoetin alfa in critically ill patients. , 2007, The New England journal of medicine.

[28]  E. Deitch,et al.  Hematopoietic progenitor cells mobilize to the site of injury after trauma and hemorrhagic shock in rats. , 2007, The Journal of trauma.

[29]  L. Kanz,et al.  Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. , 2007, Seminars in hematology.

[30]  N. Andrews,et al.  Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. , 2007, Blood.

[31]  A. Charles,et al.  Blood Transfusion is an Independent Predictor of Mortality after Blunt Trauma , 2007, The American surgeon.

[32]  W. Ertel,et al.  Erythropoiesis in multiply injured patients. , 2006, The Journal of trauma.

[33]  J. Chiche,et al.  Erythropoiesis abnormalities contribute to early-onset anemia in patients with septic shock. , 2006, American journal of respiratory and critical care medicine.

[34]  P. Rameshwar,et al.  The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6. , 2005, The Journal of trauma.

[35]  S. Vaulont,et al.  Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. , 2005, Blood.

[36]  T. Ganz,et al.  Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. , 2005, Blood.

[37]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[38]  R. Gamelli,et al.  Bone Marrow Norepinephrine Mediates Development of Functionally Different Macrophages After Thermal Injury and Sepsis , 2004, Annals of surgery.

[39]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[40]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[41]  Pranela Rameshwar,et al.  Bone Marrow Failure Following Severe Injury in Humans , 2003, Annals of surgery.

[42]  M. Levy,et al.  Anemia and blood transfusion in trauma patients admitted to the intensive care unit. , 2003, The Journal of trauma.

[43]  Thomas M Scalea,et al.  Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. , 2003, The Journal of trauma.

[44]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[45]  P. Rameshwar,et al.  Trauma Inhibits Erythroid Burst-Forming Unit and Granulocyte-Monocyte Colony-Forming Unit Growth Through the Production of TGF-&bgr;1 by Bone Marrow Stroma , 2001, Annals of surgery.

[46]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. Schobersberger,et al.  Blunted erythropoietic response to anemia in multiply traumatized patients , 2001, Critical care medicine.

[48]  M. Corwin,et al.  Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. , 2001, Journal of critical care.

[49]  K. Eckardt,et al.  Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients* , 1999, Critical care medicine.

[50]  J. Vincent,et al.  Erythropoietin response is blunted in critically ill patients , 1997, Intensive Care Medicine.

[51]  M. Loeffler,et al.  Effects of G‐CSF on Erythropoiesis a , 1994, Annals of the New York Academy of Sciences.

[52]  M. Loeffler,et al.  Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia. , 1992, Experimental hematology.

[53]  R. Klausner,et al.  Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[54]  I. Nedzelskienė,et al.  Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. , 2017, Medicina.

[55]  Abdel-Razek,et al.  Author Index. , 2017, Shock.

[56]  P. Rameshwar,et al.  Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma. , 2004, Surgical infections.